| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |